Hottest Stock Pick for 2021

From Emerging Markets Consulting | Ad

This could be the most underrated stock available. Watch it closely.

Click here to learn more

ALLO Insider Trading (Allogene Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 26.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $9,420,452.65

Allogene Therapeutics Insider Trading History Chart

Allogene Therapeutics Share Price & Price History

^$25.74

▲ +0.08 (0.31%)

As of 09/27/2021 01:00 AM ET

Days: 30 | 90 | 365

Overnight Trade Opportunity Next Week?!

From Monument Traders Alliance | Ad

I'm looking at a BIG Overnight Trade opportunity next week...It's so big...

I'm going to give it to you FREE!

In fact, for the week of October 4-8, you can join our FREE Open House!

You can get ALL our Overnight Trade recommendations, plus ALL of our research and real-time recommendations!

Go Here to Join.

Allogene Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/9/2021	Owen N. Witte	Director	Sell	5,000	$25.54	$127,700.00	221,182
8/20/2021	Owen N. Witte	Director	Sell	10,000	$23.47	$234,700.00
8/16/2021	Veer Bhavnagri	General Counsel	Sell	5,000	$21.00	$105,000.00
7/15/2021	Veer Bhavnagri	General Counsel	Sell	5,000	$21.55	$107,750.00	426,353
6/9/2021	Owen N. Witte	Director	Sell	9,969	$25.05	$249,723.45	236,182
5/18/2021	Veer Bhavnagri	General Counsel	Sell	5,000	$30.00	$150,000.00	426,353
4/15/2021	Veer Bhavnagri	General Counsel	Sell	10,000	$32.05	$320,500.00	431,353
1/14/2021	Eric Thomas Schmidt	CFO	Sell	15,000	$30.77	$461,550.00	78,916
10/15/2020	Eric Thomas Schmidt	CFO	Sell	15,000	$40.49	$607,350.00
10/13/2020	Alison Moore	Insider	Sell	35,264	$42.00	$1,481,088.00
10/9/2020	Alison Moore	Insider	Sell	44,574	$41.00	$1,827,534.00	122,745
10/7/2020	Rafael Amado	CMO	Sell	16,538	$39.40	$651,597.20	111,677
10/6/2020	Alison Moore	Insider	Sell	44,574	$40.00	$1,782,960.00	161,536
10/6/2020	Veer Bhavnagri	General Counsel	Sell	10,000	$40.00	$400,000.00	363,902
10/1/2020	Veer Bhavnagri	General Counsel	Sell	25,000	$36.52	$913,000.00	378,902
9/21/2020	Eric Thomas Schmidt	CFO	Sell	15,000	$35.30	$529,500.00
8/3/2020	Veer Bhavnagri	General Counsel	Sell	31,553	$36.89	$1,163,990.17	385,455
6/29/2020	Group Holdings (Sbs) Advis Tpg	Major Shareholder	Sell	24,904	$43.27	$1,077,596.08
6/26/2020	Group Holdings (Sbs) Advis Tpg	Major Shareholder	Sell	500	$44.01	$22,005.00
6/24/2020	Group Holdings (Sbs) Advis Tpg	Major Shareholder	Sell	15,269	$43.93	$670,767.17
6/22/2020	Group Holdings (Sbs) Advis Tpg	Major Shareholder	Sell	172,425	$42.83	$7,384,962.75
6/19/2020	Group Holdings (Sbs) Advis Tpg	Major Shareholder	Sell	47,767	$42.04	$2,008,124.68
6/17/2020	Group Holdings (Sbs) Advis Tpg	Major Shareholder	Sell	87,319	$42.18	$3,683,115.42
6/15/2020	Group Holdings (Sbs) Advis Tpg	Major Shareholder	Sell	129,154	$42.14	$5,442,549.56
6/4/2020	Arie Belldegrun	Director	Buy	146,382	$43.00	$6,294,426.00
6/3/2020	Group Holdings (Sbs) Advis Tpg	Major Shareholder	Sell	487,402	$47.40	$23,102,854.80
3/16/2020	Alison Moore	Insider	Sell	3,750	$19.19	$71,962.50
3/16/2020	David D Chang	CEO	Sell	20,335	$19.31	$392,668.85	2,215,426
3/16/2020	Eric Thomas Schmidt	CFO	Sell	5,450	$19.73	$107,528.50	47,257
9/18/2019	Alison Moore	Insider	Sell	48,827	$32.11	$1,567,834.97
7/30/2019	Alison Moore	Insider	Sell	48,827	$29.44	$1,437,466.88
6/3/2019	Alison Moore	Insider	Sell	48,828	$26.76	$1,306,637.28
5/14/2019	Group Holdings (Sbs) Advis Tpg	Major Shareholder	Sell	1,918,755	$29.38	$56,373,021.90
10/15/2018	Arie Belldegrun	Director	Buy	35,000	$18.00	$630,000.00
10/15/2018	David D Chang	Insider	Buy	40,000	$18.00	$720,000.00
10/15/2018	Group Holdings (Sbs) Advis Tpg	Major Shareholder	Buy	675,000	$18.00	$12,150,000.00

Insider Trading at Allogene Therapeutics?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Allogene Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Allogene Therapeutics (NASDAQ:ALLO)

59.60% of Allogene Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Allogene Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/24/2021	Thrivent Financial for Lutherans	41,355	$1.08M	0.0%	N/A	0.029%
9/3/2021	Parametric Portfolio Associates LLC	50,633	$1.32M	0.0%	+44.6%	0.036%
8/25/2021	Marshall Wace LLP	456,591	$11.91M	0.1%	N/A	0.321%
8/25/2021	Marshall Wace North America L.P.	325,040	$8.48M	0.0%	N/A	0.229%
8/23/2021	Morgan Stanley	1,129,478	$29.46M	0.0%	+1,107.0%	0.794%
8/19/2021	Thrivent Financial for Lutherans	41,355	$1.08M	0.0%	N/A	0.029%
8/17/2021	Wells Fargo & Company MN	10,790	$0.28M	0.0%	+102.7%	0.008%
8/17/2021	Woodline Partners LP	684,755	$17.86M	0.3%	+1.8%	0.482%
8/17/2021	Invesco Ltd.	39,411	$1.03M	0.0%	+86.1%	0.028%
8/17/2021	Metropolitan Life Insurance Co NY	19,050	$0.50M	0.0%	+126,900.0%	0.013%
8/17/2021	Millennium Management LLC	505,295	$13.18M	0.0%	+78.6%	0.355%
8/17/2021	PFM Health Sciences LP	606,800	$15.83M	0.5%	-27.4%	0.427%
8/17/2021	Price T Rowe Associates Inc. MD	3,535,184	$92.20M	0.0%	+2.3%	2.486%
8/16/2021	AQR Capital Management LLC	36,717	$0.96M	0.0%	N/A	0.026%
8/16/2021	Bank of America Corp DE	163,101	$4.25M	0.0%	+176.8%	0.115%
8/16/2021	Amalgamated Bank	10,875	$0.28M	0.0%	+41.7%	0.008%
8/16/2021	UBS Asset Management Americas Inc.	398,180	$10.39M	0.0%	+76.6%	0.280%
8/16/2021	FORA Capital LLC	4,097	$0.11M	0.0%	N/A	0.003%
8/16/2021	PDT Partners LLC	163,828	$4.27M	0.3%	+101.6%	0.115%
8/16/2021	Cubist Systematic Strategies LLC	124,598	$3.25M	0.0%	+343.4%	0.088%
8/16/2021	California State Teachers Retirement System	93,700	$2.44M	0.0%	+15.3%	0.066%
8/16/2021	Capital International Investors	3,525,114	$91.94M	0.0%	-46.6%	2.479%
8/16/2021	Royal Bank of Canada	93,066	$2.43M	0.0%	+2.5%	0.065%
8/16/2021	Tudor Investment Corp Et Al	98,912	$2.58M	0.0%	N/A	0.070%
8/16/2021	Morgan Stanley	1,129,478	$29.46M	0.0%	+1,107.0%	0.794%
8/16/2021	Amundi	5,076	$0.13M	0.0%	N/A	0.004%
8/16/2021	Credit Suisse AG	73,972	$1.93M	0.0%	+18.8%	0.052%
8/16/2021	Schonfeld Strategic Advisors LLC	104,279	$2.72M	0.0%	N/A	0.073%
8/16/2021	Charles Schwab Investment Management Inc.	634,369	$16.55M	0.0%	+12.7%	0.446%
8/16/2021	State Street Corp	3,004,900	$78.37M	0.0%	+28.8%	2.113%
8/16/2021	Nuveen Asset Management LLC	573,604	$14.96M	0.0%	+151.5%	0.403%
8/16/2021	Goldman Sachs Group Inc.	1,715,387	$44.74M	0.0%	+33.9%	1.206%
8/16/2021	Marshall Wace LLP	456,591	$11.91M	0.1%	N/A	0.321%
8/16/2021	Allianz Asset Management GmbH	15,965	$0.42M	0.0%	N/A	0.011%
8/13/2021	Renaissance Technologies LLC	704,400	$18.37M	0.0%	N/A	0.495%
8/13/2021	Northern Trust Corp	735,094	$19.17M	0.0%	+13.4%	0.517%
8/13/2021	Virginia Retirement Systems ET AL	9,800	$0.26M	0.0%	N/A	0.007%
8/13/2021	Neuberger Berman Group LLC	8,085	$0.21M	0.0%	-50.2%	0.006%
8/13/2021	Geode Capital Management LLC	1,228,081	$32.03M	0.0%	+14.5%	0.864%
8/13/2021	Vanguard Group Inc.	6,602,306	$172.19M	0.0%	+10.8%	4.644%
8/13/2021	Vident Investment Advisory LLC	60,621	$1.58M	0.0%	+1.8%	0.043%
8/13/2021	FMR LLC	663,849	$17.31M	0.0%	+17.4%	0.467%
8/13/2021	Seven Eight Capital LP	33,100	$0.86M	0.1%	N/A	0.023%
8/13/2021	ProShare Advisors LLC	45,476	$1.19M	0.0%	+29.5%	0.032%
8/13/2021	Navalign LLC	64,428	$1.68M	0.7%	N/A	0.045%
8/12/2021	Trexquant Investment LP	24,321	$0.63M	0.1%	N/A	0.017%
8/12/2021	AGF Investments LLC	24,454	$0.64M	0.1%	N/A	0.017%
8/12/2021	Lazard Asset Management LLC	1,848	$48K	0.0%	N/A	0.001%
8/12/2021	AlphaCrest Capital Management LLC	81,305	$2.12M	0.1%	+398.8%	0.057%
8/12/2021	SG Americas Securities LLC	78,414	$2.05M	0.0%	-4.4%	0.055%
8/12/2021	Advisory Services Network LLC	3,900	$0.10M	0.0%	N/A	0.003%
8/12/2021	CNA Financial Corp	17,271	$0.45M	0.1%	+15.3%	0.012%
8/12/2021	State of Wisconsin Investment Board	88,000	$2.30M	0.0%	+21.4%	0.062%
8/12/2021	Pier Capital LLC	278,828	$7.27M	0.7%	+1.9%	0.196%
8/12/2021	Legal & General Group Plc	36,768	$0.96M	0.0%	-1.3%	0.026%
8/12/2021	JPMorgan Chase & Co.	2,484,735	$64.80M	0.0%	+4.3%	1.748%
8/12/2021	Bank of Nova Scotia	19,287	$0.50M	0.0%	N/A	0.014%
8/12/2021	The Manufacturers Life Insurance Company	39,618	$1.03M	0.0%	+24.3%	0.028%
8/11/2021	Bank of New York Mellon Corp	282,337	$7.36M	0.0%	+27.1%	0.199%
8/11/2021	BlackRock Inc.	7,021,939	$183.13M	0.0%	+12.0%	4.939%
8/11/2021	Deutsche Bank AG	233,783	$6.10M	0.0%	+16.9%	0.164%
8/11/2021	Panagora Asset Management Inc.	30,264	$0.79M	0.0%	N/A	0.021%
8/11/2021	Ghost Tree Capital LLC	275,000	$7.17M	2.0%	N/A	0.193%
8/10/2021	Virtus ETF Advisers LLC	8,817	$0.23M	0.1%	-17.8%	0.006%
8/10/2021	AGF Investments Inc.	7,372	$0.19M	0.0%	N/A	0.005%
8/10/2021	Primecap Management Co. CA	3,577,030	$93.29M	0.1%	+174.0%	2.516%
8/10/2021	Principal Financial Group Inc.	141,935	$3.70M	0.0%	+2.6%	0.100%
8/10/2021	BNP Paribas Arbitrage SA	2,636	$69K	0.0%	-62.1%	0.002%
8/10/2021	State Board of Administration of Florida Retirement System	22,684	$0.59M	0.0%	+5.0%	0.016%
8/10/2021	Citigroup Inc.	198,288	$5.17M	0.0%	+60.0%	0.139%
8/10/2021	Rafferty Asset Management LLC	99,943	$2.61M	0.0%	+15.4%	0.070%
8/10/2021	WINTON GROUP Ltd	31,666	$0.83M	0.0%	+59.1%	0.022%
8/9/2021	Souders Financial Advisors	22,518	$0.59M	0.2%	+23.7%	0.016%
8/9/2021	Affinity Investment Advisors LLC	29,757	$0.78M	0.4%	+32.4%	0.021%
8/9/2021	Duality Advisers LP	37,372	$0.98M	0.1%	N/A	0.026%
8/9/2021	ClariVest Asset Management LLC	17,108	$0.45M	0.0%	+65.7%	0.012%
8/6/2021	HighTower Advisors LLC	46,309	$1.21M	0.0%	-4.1%	0.033%
8/6/2021	Ameritas Investment Partners Inc.	5,332	$0.14M	0.0%	+16.1%	0.004%
8/6/2021	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	101,373	$2.64M	0.0%	+69.8%	0.072%
8/6/2021	Swiss National Bank	170,500	$4.45M	0.0%	+18.2%	0.120%
8/6/2021	Twin Lakes Capital Management LLC	3,537	$92K	0.1%	-17.6%	0.002%
8/5/2021	Rhumbline Advisers	87,830	$2.29M	0.0%	+43.1%	0.062%
8/5/2021	Los Angeles Capital Management LLC	30,513	$0.80M	0.0%	-9.2%	0.022%
8/5/2021	Teacher Retirement System of Texas	7,815	$0.20M	0.0%	+18.8%	0.006%
8/5/2021	GSA Capital Partners LLP	13,951	$0.36M	0.0%	N/A	0.010%
8/4/2021	Russell Investments Group Ltd.	1,308	$34K	0.0%	-97.7%	0.001%
8/3/2021	Handelsbanken Fonder AB	12,700	$0.33M	0.0%	+8.5%	0.009%
8/3/2021	Victory Capital Management Inc.	60,268	$1.57M	0.0%	-93.6%	0.043%
8/3/2021	Oppenheimer & Co. Inc.	14,884	$0.39M	0.0%	-40.5%	0.011%
8/2/2021	Arizona State Retirement System	21,028	$0.55M	0.0%	+14.4%	0.015%
8/2/2021	New York State Common Retirement Fund	58,749	$1.53M	0.0%	+20.1%	0.042%
8/2/2021	Advisor Group Holdings Inc.	8,138	$0.21M	0.0%	+34.9%	0.006%
8/1/2021	Dupont Capital Management Corp	13,341	$0.35M	0.0%	N/A	0.009%
7/31/2021	Bourgeon Capital Management LLC	33,300	$0.87M	0.2%	N/A	0.024%
7/30/2021	Alliancebernstein L.P.	3,166,630	$82.59M	0.0%	+24.6%	2.237%
5/24/2021	Principal Financial Group Inc.	138,328	$4.88M	0.0%	+11.0%	0.098%
5/19/2021	Twin Lakes Capital Management LLC	4,293	$0.15M	0.1%	N/A	0.003%
5/18/2021	Millennium Management LLC	282,965	$9.99M	0.0%	-45.1%	0.200%
5/18/2021	State of Wisconsin Investment Board	72,500	$2.56M	0.0%	-4.1%	0.051%
5/18/2021	Morgan Stanley	93,580	$3.30M	0.0%	-72.7%	0.066%

Data available starting January 2016

Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Its engineered T cells are allogeneic, which are derived from healthy donors for intended use in any patient. The company was founded by Arie S. Belldegrun, David D. Chang, David M. Tanen, and Joshua A. Kazam in November 2017 and is headquartered in South San Francisco, CA.

Today's Range

Now: $25.74

$25.13

$26.21

50 Day Range

MA: $23.65

$21.01

$27.64

52 Week Range

Now: $25.74

$20.58

$44.92

Volume

643,807 shs

Average Volume

982,589 shs

Market Capitalization

$3.66 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.09

Who are the company insiders with the largest holdings of Allogene Therapeutics?: Allogene Therapeutics' top insider shareholders include:
David D Chang (CEO)
Veer Bhavnagri (General Counsel)
Owen N Witte (Director)
Owen N Witte (Director)
Alison Moore (Insider)
Rafael Amado (CMO)
Eric Thomas Schmidt (CFO)
Arie Belldegrun (Director)
Group Holdings (Sbs) Advis Tpg (Major Shareholder)
Who are the major institutional investors of Allogene Therapeutics?: Allogene Therapeutics' top institutional shareholders include:
BlackRock Inc. — 4.94%
Vanguard Group Inc. — 4.64%
Primecap Management Co. CA — 2.52%
Price T Rowe Associates Inc. MD — 2.49%
Capital International Investors — 2.48%
Alliancebernstein L.P. — 2.24%
Which institutional investors are selling Allogene Therapeutics stock?: During the previous quarter, ALLO stock was sold by these institutional investors:
Capital International Investors
Victory Capital Management Inc.
PFM Health Sciences LP
Russell Investments Group Ltd.
Citadel Advisors LLC
Oppenheimer & Co. Inc.
Neuberger Berman Group LLC
BNP Paribas Arbitrage SA
Within the previous year, company insiders that have sold Allogene Therapeutics company stock include:
David D Chang (CEO)
Veer Bhavnagri (General Counsel)
Owen N Witte (Director)
Owen N Witte (Director)
Alison Moore (Insider)
Rafael Amado (CMO)
Which institutional investors are buying Allogene Therapeutics stock?: During the previous quarter, ALLO stock was acquired by institutional investors including:
Primecap Management Co. CA
Morgan Stanley
Morgan Stanley
BlackRock Inc.
Renaissance Technologies LLC
State Street Corp
Vanguard Group Inc.
Alliancebernstein L.P.